erythro-Austrobailignan-6 ( —— )

产品货号. M32474 CAS No. 114127-24-1

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

产品询价大包装询价加入购物车

产品名称

erythro-Austrobailignan-6
注意事项

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
产品简述

erythro-Austrobailignan-6 is an orally active anti-cancer agent. erythro-Austrobailignan-6 inhibits DNA topoisomerase I and II activity. erythro-Austrobailignan-6 induces cell apoptosis and increases phosphorylation of p38 and JNK.
产品描述

erythro-Austrobailignan-6 is an orally active anti-cancer agent. erythro-Austrobailignan-6 inhibits DNA topoisomerase I and II activity. erythro-Austrobailignan-6 induces cell apoptosis and increases phosphorylation of p38 and JNK .
体外实验

Cell Viability Assay Cell Line:4T-1 and MCF-7 cells Concentration:0-30 μM Incubation Time:24 or 48 h Result:Dose dependently inhibited cell proliferation.Western Blot Analysis Cell Line:4T-1 and MCF-7 cells Concentration:100 μM Incubation Time:30, 60 or 120 min Result:Increased phosphorylation of p38 and JNK.Activated caspase-3 and inhibited CDK-4 and cyclin D1.
体内实验

Animal Model:4T-1 tumor bearing mice Dosage:20 mg/kg/day Administration:Food intake Result:Inhibited tumor growth by 40.8%;Down-regulated CDK-4, cyclin D1, HER2 and integrin β3; Up-regulated cleaved caspase-3 in tumor.
同义词

——
通路

Others
靶点

Other Targets
受体

——
研究领域

——
适应症

——

计算器

产品手册

关联产品

RSK Substrate, S6 (2...

RSK Substrate, S6 (231-239)
TRH-βNA

TRH-βNA 是测定膜 TRH 脱氨酶 (TRH-DE) 活性和膜焦谷氨酰氨基肽酶 II (PPII) 活性的底物。
Ac2-26 TFA (151988-3...

Ac2-26 TFA, an active N-terminal peptide of annexin A1 (AnxA1), attenuates ischemia-reperfusion-induced acute lung injury. Ac2-26 also decreases AnxA1 protein expression, inhibits the activation of NF-κB and MAPK pathways in the injured lung tissue.